Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Debt Ratio (2022 - 2023)

Pasithea Therapeutics' (KTTAW) quarterly Debt Ratio came in at 0.0 in Q2 2023, down 44.36% quarter-over-quarter from 0.01 in Q1 2023.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Debt Ratio (2022 - 2023) Analysis & Trends

Pasithea Therapeutics has disclosed Debt Ratio across 2 years of filings, most recently posting 0.0 for Q2 2023.

  • In Q2 2023, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2023 stood at 0.0 (changed N/A YoY), while the FY2022 annual figure was 0.0, changed N/A from the prior year.
  • Debt Ratio came in at 0.0 for Q2 2023 at Pasithea Therapeutics, down from 0.01 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.01 in Q1 2023 to a low of 0.0 in Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 0.00
Mar 31, 2023 0.01
Dec 31, 2022 0.00